Skip to content
16 November · 06:30 UTCFollow AstraZeneca by emailFollow

AZN · Pharma and healthcare · one day

AstraZeneca (AZN): news on Monday 16 November 2026

News from the 24 hours to Monday morning, 16 November 2026.

Tone of the day

+4.5positive
Relevant headlines6of 9 read
Stories—grouped by event

What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

Why it scored this way

Coverage was mixed but leaned positive, with upheld quarterly growth guidance, reduced trial risk for Imfinzi and a new R&D centre. Reports of about 600 US sales job cuts weighed on the tone.

What drove it

  • Q3 results and guidance
  • US sales job cuts
  • R&D expansion

Around this day

DayToneHeadlines
Tue 10 Nov+5.512
Wed 11 Nov+6.322
Thu 12 Nov+7.525
Fri 13 Nov+5.38
Sat 14 Nov+5.539
Sun 15 Nov+7.59
Mon 16 Nov+4.56

0 headlines · strongest first

Pharma and healthcare on 16 NovemberFTSE 100 that day
ToneWhat the article reported, and why it scored that waySource

Each article has its own score. The lines are our own summary; follow the source link to read the article itself.

Follow by email

A short, free morning email on how the news treated AstraZeneca: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

How it works. Every morning an AI model reads the UK business news about each FTSE 100 company and scores how good or bad it is for the company, from −10 to +10. Pages update by about 07:45 UK time.

Not investment advice. MarketFrame rates the tone of news coverage. It is general information, not a recommendation to buy or sell anything. The scores are not share-price data or forecasts: a good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.

Data to 06:30 UTC, 16 November · 220 headlines · 52 companiesMade by Adapt Progress Evolve Limited, a UK company · Privacy · Terms · Who we are · RSS · API · llms.txt